Equifax Reaches New 52-Week High (EFX)

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

NEW YORK ( TheStreet) -- Equifax (NYSE: EFX) hit a new 52-week high Tuesday as it is currently trading at $58.02, above its previous 52-week high of $57.24 with 727,417 shares traded as of 1:50 p.m. ET. Average volume has been 885,300 shares over the past 30 days.

Equifax has a market cap of $6.99 billion and is part of the financial sector and financial services industry. Shares are up 8% year to date as of the close of trading on Friday.

Equifax Inc. collects, organizes, and manages various financial, demographic, employment, and marketing information solutions for businesses and consumers. The company's U.S. The company has a P/E ratio of 23.4, above the S&P 500 P/E ratio of 17.7.

  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

TheStreet Ratings rates Equifax as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, impressive record of earnings per share growth and compelling growth in net income. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. You can view the full Equifax Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.

It's Official: Action Alerts PLUS beats the S&P 500 with Dividends Reinvested! Cramer and Link were up 16.72% in 2012. Were you? See what they are trading for 14-days FREE.
null

If you liked this article you might like

Cramer: FedEx Will Win Big With Global E-Commerce Growth 'On Steroids'

Elizabeth Warren Slams Wells Fargo, Equifax: Cramer's Top Takeaways

How Long Can This Rally Run?: Cramer's 'Mad Money' Recap (Monday 9/19/17)

Wall Street Overlooks Trump's North Korea Threats to Hit New Records